Integration of transcriptomics, proteomics and loss-of-function screening reveals WEE1 as a target for combination with dasatinib against proneural glioblastoma
Titel:
Integration of transcriptomics, proteomics and loss-of-function screening reveals WEE1 as a target for combination with dasatinib against proneural glioblastoma
Auteur:
Alhalabi, Obada T. Göttmann, Mona Gold, Maxwell P. Schlue, Silja Hielscher, Thomas Iskar, Murat Kessler, Tobias Hai, Ling Lokumcu, Tolga Cousins, Clara C. Herold-Mende, Christel Heßling, Bernd Horschitz, Sandra Jabali, Ammar Koch, Philipp Baumgartner, Ulrich Day, Bryan W. Wick, Wolfgang Sahm, Felix Krieg, Sandro M. Fraenkel, Ernest Phillips, Emma Goidts, Violaine